Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.304
-0.044 (-3.26%)
Oct 22, 2026, 5:35 PM CEST
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €122.19 million as of October 22, 2026. It is the 23,048th most valuable company in the world and the 276th biggest in France. Its market cap has decreased by 26.35% in one year.
Market Cap
122.19M
Enterprise Value
131.50M
Revenue
9.81M
Global Rank
Country Rank
#276 France
PE Ratio
n/a
ChartMarket Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 122.19M, an increase of 15,325.16%. That is a compound annual growth rate of 28.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 122.19M | -17.26% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 468.81M |
| Genfit | 463.79M |
| Valerio Therapeutics Société anonyme | 200.28M |
| Transgene | 185.69M |
| Sensorion | 94.91M |
| Cellectis | 72.33M |
| ABIONYX Pharma | 69.60M |
| OSE Immunotherapeutics | 48.69M |